Puma Biotechnology Inc’s filing revealed that its President and CEO AUERBACH ALAN H unloaded Company’s shares for reported $0.19 million on Jan 03 ’24. In the deal valued at $4.49 per share,41,396 shares were sold. As a result of this transaction, AUERBACH ALAN H now holds 6,936,947 shares worth roughly $40.44 million.
Then, NOUGUES MAXIMO F sold 15,682 shares, generating $70,348 in total proceeds. Upon selling the shares at $4.49, the Chief Financial Officer now owns 128,666 shares.
Before that, Ludwig Jeffrey Jerome sold 12,956 shares. Puma Biotechnology Inc shares valued at $58,119 were divested by the Chief Commercial Officer at a price of $4.49 per share. As a result of the transaction, Ludwig Jeffrey Jerome now holds 99,970 shares, worth roughly $0.58 million.
Citigroup upgraded its Puma Biotechnology Inc [PBYI] rating to a Buy from a a Neutral in a research note published recently. Goldman also remained covering PBYI and has decreased its forecast on October 08, 2019 with a “Sell” recommendation from previously “Neutral” rating. Citigroup revised its rating on May 10, 2019. It rated PBYI as “a Neutral” which previously was an “a Buy”.
Price Performance Review of PBYI
On Tuesday, Puma Biotechnology Inc [NASDAQ:PBYI] saw its stock jump 3.55% to $5.83. Over the last five days, the stock has gained 10.42%. Puma Biotechnology Inc shares have risen nearly 34.64% since the year began. Nevertheless, the stocks have risen 93.69% over the past one year. While a 52-week high of $7.73 was reached on 02/15/24, a 52-week low of $2.13 was recorded on 01/02/24. SMA at 50 days reached $5.60, while 200 days put it at $4.06. A total of 0.55 million shares were traded, compared to the trading of 0.53 million shares in the previous session.
Levels Of Support And Resistance For PBYI Stock
The 24-hour chart illustrates a support level at 5.60, which if violated will result in even more drops to 5.36. On the upside, there is a resistance level at 6.06. A further resistance level may holdings at 6.29. The Relative Strength Index (RSI) on the 14-day chart is 57.59, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.28, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 12.40%. Stochastics %K at 88.22% indicates the stock is a selling.
How much short interest is there in Puma Biotechnology Inc?
A steep rise in short interest was recorded in Puma Biotechnology Inc stocks on Mar 15, 2024, dropping by -0.26 million shares to a total of 3.33 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 3.59 million shares. There was a decline of -7.81%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 8.11% of the overall stock float, the days-to-cover ratio (short ratio) fell to 4.42.
